The Therapeutic Drug Monitoring market size is USD 2.8 Bn in 2026.
The Therapeutic Drug Monitoring market is projected to grow at a CAGR of 10% by 2033.
The Therapeutic Drug Monitoring market growth drivers include rising adoption of precision medicine, increasing prevalence of chronic and cardiovascular diseases, and advancements in wearable biosensors and diagnostic technologies.
North America is the dominating region for Therapeutic Drug Monitoring market.
Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, and Bio-Rad Laboratories are some leading industry players in the Therapeutic Drug Monitoring market.